Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s)
Not yet recruitingOBSERVATIONAL
Enrollment
60
Participants
Timeline
Start Date
June 30, 2026
Primary Completion Date
June 30, 2028
Study Completion Date
September 30, 2028
Conditions
Lung CancerNSCLC
Trial Locations (1)
11566
Faculty of Pharmacy, Ain Shams University, Advanced Biochemistry Research Lab, Cairo
All Listed Sponsors
lead
Ain Shams University
OTHER
NCT06502249 - Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s) | Biotech Hunter | Biotech Hunter